This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human Matrilin-3 Protein, CF
catalog :
3017-MN
quantity :
50 ug
price :
389 USD
citations: 3
Reference
Yang X, Trehan S, Guan Y, Sun C, Moore D, Jayasuriya C, et al. Matrilin-3 inhibits chondrocyte hypertrophy as a bone morphogenetic protein-2 antagonist. J Biol Chem. 2014;289:34768-79 pubmed publisher
Wang Q, Rozelle A, Lepus C, Scanzello C, Song J, Larsen D, et al. Identification of a central role for complement in osteoarthritis. Nat Med. 2011;17:1674-9 pubmed publisher
Hills R, Mazzarella R, Fok K, Liu M, Nemirovskiy O, Leone J, et al. Identification of an ADAMTS-4 cleavage motif using phage display leads to the development of fluorogenic peptide substrates and reveals matrilin-3 as a novel substrate. J Biol Chem. 2007;282:11101-9 pubmed
product information
brand :
R&D Systems
master code :
3017-MN
SKU :
3017-MN-050
product name :
Recombinant Human Matrilin-3 Protein, CF
description :
The Recombinant Human Matrilin-3 Protein, CF from R&D Systems is derived from NS0. The Recombinant Human Matrilin-3 Protein, CF has been validated for the following applications: Binding Activity.
target :
NDUFC2
category :
Proteins and Enzymes
unit size :
50 ug
buffer :
Lyophilized from a 0.2 µm filtered solution in PBS.
conjugate :
Unconjugated
purity :
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain
species :
Human
observed molecular weight :
57 kDa, reducing conditions
theoretical molecular weight :
50.6 kDa
gene symbol :
NDUFC2
details of functionality :
Measured by its binding ability in a functional ELISA. Immobilized rhCOMP at 2 µg/mL (100 µL/well) can bind rhMatrilin-3 with a linear range of 1.5-100 ng/mL.
endotoxin note :
<0.01 EU per 1 µg of the protein by the LAL method.
catalog number base :
3017-MN
accessionNumbers :
O15232
applications :
Binding Activity
source :
Mouse myeloma cell line, NS0-derived human Matrilin-3 protein Asp29-Arg486, with a C-terminal 6-His tag
2020 USD :
369
2021 USD :
389 USD
alt names :
B14.5b, CI-B14.5b, complex I subunit B14.5b, Complex I-B14.5b, EDM5, HLC-1NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2 (14.5kD, B14.5b), HOA, Human lung cancer oncogene 1 protein, Matrilin3, NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa, NADH dehydrogenase [ubiquinone] 1 subunit C2, NADHDH2, NADH-ubiquinone oxidoreductase subunit B14.5b, NDUFC2
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.